Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL847347 | 0.84 | GPR3 (0.40) | HPGDTSHR | |
| SCHEMBL5311047 | 0.84 | — | — | |
| SCHEMBL3834477 | 0.83 | CA1 (0.38) | HPGDTSHR | |
| SCHEMBL5311043 | 0.82 | — | — | |
| Sulfuric Acid SCHEMBL6341005 | 0.76 | FAAH (0.31) | — | |
| SCHEMBL1088652 | 0.71 | GPR3 (0.34) | — | |
| SCHEMBL1087889 | 0.71 | GPR3 (0.34) | — | |
| SCHEMBL5974326 | 0.70 | CES2 (0.32) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3835272 | 0.68 | KCNH2 (0.40) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL3832689 | 0.68 | CA1 (0.40) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1935042-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS AND METHODS OF FABRICATING THE SAME | General Electric Company (US) | 2008-06-25 | — | — | EP | claimed |
| US-20070117041-A1 | Photosensitive coating for enhancing a contrast of a photolithographic exposure | INFINEON TECHNOLOGIES AG (DE) | 2007-05-24 | — | — | US | claimed |
| WO-2007040728-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS AND METHODS OF FABRICATING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2007-04-12 | — | — | WO | claimed |
| US-20070077452-A1 | Organic light emitting devices having latent activated layers and methods of fabricating the same | GENERAL ELECTRIC COMPANY | 2007-04-05 | — | — | US | claimed |
| US-6746828-B2 | INCLUDING A FILM-FORMING POLYMER CONTAINING MOLECULE GROUPS CONVERTABLE INTO ALKALI-SOLUBLE GROUPS BY ACID-CATALYZED REACTION, A PHOTOACID GENERATOR AND A THERMOBASE GENERATOR; SEMICONDUCTORS; CROSSLINKING INHIBITION; ACCURACY; SMOOTHNESS | INFINEON TECHNOLOGIES AG (DE) | 2004-06-08 | — | — | US | claimed |
| US-6740475-B2 | INCLUDING A FILM-FORMING POLYMER CONTAINING MOLECULE GROUPS CONVERTABLE INTO ALKALI-SOLUBLE GROUPS BY ACID-CATALYZED REACTION, A PHOTOACID GENERATOR AND A THERMOBASE GENERATOR; SEMICONDUCTORS; CROSSLINKING INHIBITION; ACCURACY; SMOOTHNESS | INFINEON TECHNOLOGIES AG (DE) | 2004-05-25 | — | — | US | claimed |
| US-20020160318-A1 | Method for structuring a photoresist layer | POLARIS INNOVATIONS LIMITED (IE) | 2002-10-31 | — | — | US | claimed |
| US-20020160316-A1 | Process for structuring a photoresist layer | POLARIS INNOVATIONS LIMITED (IE) | 2002-10-31 | — | — | US | claimed |
| CN-101283462-B | Organic light emitting device having an intrinsic active layer and method of fabricating the same | GEN ELECTRIC | 2011-08-24 | — | — | CN | disclosed |
| US-20100230829-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS AND METHODS OF FABRICATING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2010-09-16 | — | — | US | disclosed |
| EP-2067192-A2 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS | GENERAL ELECTRIC COMPANY (US) | 2009-06-10 | — | — | EP | disclosed |
| CN-101283462-A | Organic light emitting device having an intrinsic active layer and method of fabricating the same | GEN ELECTRIC (US) | 2008-10-08 | — | — | CN | disclosed |
| WO-2008094294-A2 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS | GENERAL ELECTRIC COMPANY (US) | 2008-08-07 | — | — | WO | disclosed |
| EP-1935042-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS AND METHODS OF FABRICATING THE SAME | General Electric Company (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20070077452-A1 | Organic light emitting devices having latent activated layers and methods of fabricating the same | GENERAL ELECTRIC COMPANY | 2007-04-05 | — | — | US | disclosed |
| US-20070075628-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS | GENERAL ELECTRIC COMPANY (US) | 2007-04-05 | — | — | US | disclosed |
| US-6746828-B2 | INCLUDING A FILM-FORMING POLYMER CONTAINING MOLECULE GROUPS CONVERTABLE INTO ALKALI-SOLUBLE GROUPS BY ACID-CATALYZED REACTION, A PHOTOACID GENERATOR AND A THERMOBASE GENERATOR; SEMICONDUCTORS; CROSSLINKING INHIBITION; ACCURACY; SMOOTHNESS | INFINEON TECHNOLOGIES AG (DE) | 2004-06-08 | — | — | US | disclosed |
| US-6740475-B2 | INCLUDING A FILM-FORMING POLYMER CONTAINING MOLECULE GROUPS CONVERTABLE INTO ALKALI-SOLUBLE GROUPS BY ACID-CATALYZED REACTION, A PHOTOACID GENERATOR AND A THERMOBASE GENERATOR; SEMICONDUCTORS; CROSSLINKING INHIBITION; ACCURACY; SMOOTHNESS | INFINEON TECHNOLOGIES AG (DE) | 2004-05-25 | — | — | US | disclosed |
| US-20020160318-A1 | Method for structuring a photoresist layer | POLARIS INNOVATIONS LIMITED (IE) | 2002-10-31 | — | — | US | disclosed |
| US-20020160316-A1 | Process for structuring a photoresist layer | POLARIS INNOVATIONS LIMITED (IE) | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100230829-A1 | ORGANIC LIGHT EMITTING DEVICES HAVING LATENT ACTIVATED LAYERS AND METHODS OF FABRICATING THE SAME | LIN28A, ACHE, GLA | HPGD 2069/4885TSHR 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.